Board of Directors

Black Lives Matter | An Important Message from the FDLI Board of Directors
2020 Board Members Announced | Press Release

Jennifer L. Bragg | Read Bio
Partner, Skadden, Arps, Slate,
Meagher & Flom LLP
Chair

Daniel Kracov | Read Bio
Partner, Arnold & Porter LLP
Vice Chair

Freddy A. Jimenez | Read Bio
Vice President, Law and Compliance, Celldex Therapeutics
Secretary and General Counsel

Frederick R. Ball | Read Bio
Partner, Duane Morris LLP
Treasurer

Amy Comstock Rick | Read Bio
Food and Drug Law Institute
President and CEO

At-Large Directors

Cathy L. Burgess | Read Bio
Partner, Alston & Bird LLP

Carla Cartwright | Read Bio
Director, Global Regulatory Policy, Johnson & Johnson

Dean R. Cirotta | Read Bio
President, EAS Consulting Group

Jeffrey Francer | Read Bio
Senior Vice President and General Counsel, Association for Accessible Medicines

Miriam Guggenheim | Read Bio
Partner, Covington & Burling, LLP

Sandra Cohen Kalter | Read Bio
Vice President and Chief Regulatory Counsel, Medtronic

Amy Norris | Read Bio
Executive Counsel, Clif Bar & Company

Francis B. Palumbo | Read Bio
Professor & Executive Director, University of Maryland School of Pharmacy, Center on Drugs & Public Policy

Margaret (Mimi) Foster Riley | Read Bio
Professor, University of Virginia, Schools of Law and Medicine

Cynthia Schnedar | Read Bio 
Executive Vice President, Greenleaf Health, Inc.

Rachel Turow | Read Bio 
Executive Counsel, Regulatory Law, TEVA Pharmaceuticals USA, Inc.